The most intriguing feature of ERBB3 is that it contains multiple binding sites for the p85 regulatory subunit of PI3K [13, 14], allowing it to activate the AKT pathway, a critical signal in a variety of cancers [15]. This evidence concerns the gene ERBB3 and cancer.